Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
Jeroen F. Vermeulen, Wim Van Hecke, Elisabeth J. M. Adriaansen, et al.
OncoImmunology (2017) Vol. 7, Iss. 3, pp. e1398877-e1398877
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 286
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Somayeh Vafaei, Angelina Olegovna Zekiy, Ramadhan Ado Khanamir, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 176
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska, Alan Mackay, Patricia O’Hare, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 161
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 17
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
Maojin Yao, Patrick Ventura, Ying Jiang, et al.
Cell (2020) Vol. 180, Iss. 3, pp. 502-520.e19
Open Access | Times Cited: 123
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Michael Bockmayr, Malte Mohme, Frederick Klauschen, et al.
OncoImmunology (2018) Vol. 7, Iss. 9, pp. e1462430-e1462430
Open Access | Times Cited: 101
Integrative analysis of gene expression and DNA methylation through one‐class logistic regression machine learning identifies stemness features in medulloblastoma
Hao Lian, Yipeng Han, Yuchao Zhang, et al.
Molecular Oncology (2019) Vol. 13, Iss. 10, pp. 2227-2245
Open Access | Times Cited: 96
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, et al.
Seminars in Cancer Biology (2020) Vol. 79, pp. 18-43
Open Access | Times Cited: 60
Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond
Jesús García-López, Rahul Kumar, Kyle Smith, et al.
Trends in Genetics (2020) Vol. 37, Iss. 3, pp. 235-250
Closed Access | Times Cited: 57
Updates on Management of Adult Medulloblastoma
Nazanin Majd, Marta Peñas-Prado
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 8
Closed Access | Times Cited: 56
CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model
I‐Li Tan, Raquel Duque do Nascimento Arifa, Harikrishna Rallapalli, et al.
Oncogene (2020) Vol. 40, Iss. 2, pp. 396-407
Open Access | Times Cited: 52
PD-L1 expression in medulloblastoma: an evaluation by subgroup
Allison Martin, Christopher J. Nirschl, Magda J. Polanczyk, et al.
Oncotarget (2018) Vol. 9, Iss. 27, pp. 19177-19191
Open Access | Times Cited: 55
CAR T Cell Therapy for Pediatric Brain Tumors
John Patterson, J. Curran Henson, Rebecca O. Breese, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 49
CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
Jakob Nikolas Kather, Christian Hörner, Cleo‐Aron Weis, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Tumor-Specific T Cell Activation in Malignant Brain Tumors
Malte Mohme, Marian C. Neidert
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 42
Immune profiling of pediatric solid tumors
Rachael Terry, Déborah Meyran, David S. Ziegler, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3391-3402
Open Access | Times Cited: 40
Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management
Margot Lazow, Joshua D. Palmer, Maryam Fouladi, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1733-1751
Open Access | Times Cited: 24
Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience
Hamza Gorsi, Denise Malicki, Valentin Barsan, et al.
Journal of Pediatric Hematology/Oncology (2018) Vol. 41, Iss. 4, pp. e235-e241
Open Access | Times Cited: 44
<p>Immunotherapy for Medulloblastoma: Current Perspectives</p>
Tanvir Kabir, Charles A. Kunos, John L. Villano, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 57-77
Open Access | Times Cited: 38
The molecular biology of medulloblastoma metastasis
Randy Van Ommeren, Livia Garzia, Borja Holgado, et al.
Brain Pathology (2019) Vol. 30, Iss. 3, pp. 691-702
Open Access | Times Cited: 37
Hedgehog Pathway Inhibitors against Tumor Microenvironment
Silpa Gampala, Jer‐Yen Yang
Cells (2021) Vol. 10, Iss. 11, pp. 3135-3135
Open Access | Times Cited: 30
Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma
Tanja Eisemann, Robert J. Wechsler‐Reya
Genes & Development (2022) Vol. 36, Iss. 9-10, pp. 514-532
Open Access | Times Cited: 20
Advances in the application of immune checkpoint inhibitors in gynecological tumors
YingGang Zou, Ying Xu, XiaoChen Chen, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109774-109774
Closed Access | Times Cited: 11
Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy
Franziska Blaeschke, Milan Paul, Martin U. Schuhmann, et al.
Cytotherapy (2019) Vol. 21, Iss. 9, pp. 973-986
Closed Access | Times Cited: 32
Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells
Mélanie Gauthier, Caroline Laroye, Danièle Bensoussan, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 160, pp. 103261-103261
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top